Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 2 Interventional

A Dose-Finding Study Evaluating Safety and Efficacy in Patients With Chronic Obstructive Pulmonary Disease

ClinicalTrials.gov ID: NCT00403286

Public ClinicalTrials.gov record NCT00403286. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Jul 21, 2026, 9:17 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Multi-Center, Randomized, Double-Blind, Parallel-Group, Dose-Finding Trial to Evaluate the Safety and Efficacy of Fluticasone Propionate Combined With Formoterol Fumarate in Patients With Chronic Obstructive Pulmonary Disease

Study identification

NCT ID
NCT00403286
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Dey
Industry
Enrollment
457 participants

Conditions and interventions

Interventions

  • Fluticasone Propionate/Formoterol Fumarate Drug
  • Fluticasone Propionate Drug
  • Formoterol Fumarate Drug
  • Fluticasone Propionate/Salmeterol Xinafoate Drug
  • Placebo Drug

Drug

Eligibility (public fields only)

Age range
40 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 31, 2006
Primary completion
Apr 30, 2007
Completion
Apr 30, 2007
Last update posted
Jun 29, 2009

2006 – 2007

United States locations

U.S. sites
49
U.S. states
28
U.S. cities
47
Facility City State ZIP Site status
Research Site Birmingham Alabama 35209
Research Site Jasper Alabama 35501
Research Site Phoenix Arizona 85006
Research Site Buena Park California 90620
Research Site Costa Mesa California 92626
Research Site Encinitas California 92024
Research Site Los Angeles California 90095
Research Site San Diego California 92120
Research Site Wheat Ridge Colorado 80033
Research Site Clearwater Florida 33765
Research Site DeLand Florida 32720
Research Site Tamarac Florida 33321
Research Site Tampa Florida 33603
Research Site Atlanta Georgia 30309
Research Site Woodstock Georgia 30189
Research Site Coeur d'Alene Idaho 83814
Research Site Hines Illinois 60141
Research Site Lenexa Kansas 66219
Research Site Topeka Kansas 66606
Research Site Madisonville Kentucky 42431
Research Site Wheaton Maryland 20902
Research Site Minneapolis Minnesota 55402
Research Site Saint Charles Missouri 63301
Research Site St Louis Missouri 63122
Research Site Henderson Nevada 89014
Research Site Cherry Hill New Jersey 08003
Research Site Albuquerque New Mexico 87108
Research Site Camillus New York 13031
Research Site Liverpool New York 13088
Research Site Charlotte North Carolina 28207
Research Site Greenville North Carolina 29615
Research Site Morrisville North Carolina 27560
Research Site Raleigh North Carolina 27607
Research Site Cincinnati Ohio 45227
Research Site Cincinnati Ohio 45231
Research Site Cincinnati Ohio 45242
Research Site Oklahoma City Oklahoma 73104
Research Site Medford Oregon 97504
Research Site Portland Oregon 97213
Research Site East Providence Rhode Island 02914
Research Site Spartanburg South Carolina 29303
Research Site Austin Texas 78750
Research Site Dallas Texas 75231
Research Site San Antonio Texas 78229
Research Site South Burlington Vermont 05403
Research Site Abingdon Virginia 24210
Research Site Richmond Virginia 23225
Research Site Tacoma Washington 98405
Research Site Milwaukee Wisconsin 53217

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00403286, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2009 · Synced Jul 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00403286 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →